SCHEMBL18398295

SCHEMBL18398295

CCc1cc(F)ccc1Nc1cc2c(ncn2C)c(C(N)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K2 P36507 3/20 0.40
▸ MAP2K1 Q02750 3/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ NQO2 P16083 1/20 0.40
▸ SMC2 O95347 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ CSNK2A2 P19784 1/20 0.37
▸ SMC1A Q14683 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ Q6ZSR9 Q6ZSR9 1/20 0.37
▸ BMP2K Q9NSY1 1/20 0.37
▸ MAPK14 Q16539 5/20 0.35
▸ EGLN1 Q9GZT9 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ SYK P43405 2/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ CSF1R P07333 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398296 0.85 JAK2 (0.37) MAP2K2MAP2K1ABCB11NQO2SMC2
SCHEMBL18398418 0.84 MAP2K2 (0.38) MAP2K2MAP2K1ABCB11NQO2SMC2
SCHEMBL18398577 0.79 JAK2 (0.48) SYKKCNH2
SCHEMBL18398493 0.79 PPARG (0.46) EGLN1LMNAPKM
SCHEMBL18409114 0.79 TYK2 (0.46) MAPK14ABL1
SCHEMBL18398530 0.79 MAPK14 (0.36) MAP2K2MAP2K1ABCB11NQO2MAPK14
SCHEMBL18398396 0.76 JAK1 (0.44) MAP2K2MAP2K1ABCB11NQO2SMC2
SCHEMBL15175025 0.75 GABRG2 (0.41) LMNAP2RX7
SCHEMBL18398495 0.72 MAPT (0.43) LMNAP2RX7PKM
SCHEMBL18398607 0.71 JAK2 (0.45) MAP2K2MAP2K1ABCB11NQO2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback